Global Intragastric Balloon Market Size, Share and Global Outlook 2022-2030

According to Inkwood Research, the Global Intragastric Balloon Market is evaluated to record a CAGR of 12.14% in terms of revenue during the projected period, 2019-2028.
"Browse 34 Market Data Tables and 40 Figures spread over 180 Pages, along with an in-depth TOC on the Global Intragastric Balloon Market Forecast 2019-2028."

REQUEST CUSTOMIZATION LINK - https://www.inkwoodresearch.com/request-for-custom-report/

REQUEST FREE SAMPLE LINK - https://www.inkwoodresearch.com/reports/intragastric-balloons-market/#request-free-sample

VIEW TABLE OF CONTENT LINK - https://www.inkwoodresearch.com/reports/intragastric-balloons-market/#table-of-contents

BUY NOW- https://www.inkwoodresearch.com/reports/intragastric-balloons-market/
The intragastric balloon is a device-based bariatric procedure that serves a temporary function of aiding excess weight loss for around 6-12 months, by limiting food intake. The intragastric ballooning procedure is very simple and does not require invasive surgery. The balloon is first passed into the stomach through the mouth with an endoscope. Once the balloon is introduced into the stomach, it is inflated with air or filled with saline or methylene blue, to fill the stomach space. After inflation, the tube and endoscope are then pulled out, leaving the balloon inside. However, there are risks involved in the procedure, including internal bleeding, respiratory problems, and even death resulting from leaks from internal incision sites.

Unhealthy lifestyles are accelerating the Global Market Growth
In addition to behavioral factors, the health of an individual is primarily defined by the lifestyle they lead, thus influencing their weight. An unhealthy diet, smoking, reduced or lack of physical activity, and exercise are primary concerns associated with lifestyle. Consequently, these detrimental factors have resulted in obesity and being overweight. The extra fat produced by the body hinders cell functioning and causes lifestyle disorders like high blood pressure or hypertension, diabetes mellitus, metabolic syndromes, a stroke, aneurysm, and Chronic Obstructive Pulmonary Disease (COPD). Moreover, it can also result in diverse types of cancers, such as pancreas, esophagus, colon, and breast (post-menopause), among several others. Thus, the prevalence of unhealthy lifestyles across the world is driving the global intragastric balloon market growth.
To know more about this report, request a free sample copy.

Clinics are the major End-users in terms of Market Share
The intragastric balloon helps obese patients lose weight without the need for surgery, and Cleveland Clinic, America, is among the first centers in the country to implement the procedure. The intragastric balloon system secured its approval from the U.S. Food and Drug Administration as it delivered new non-surgical treatment options for patients who failed at losing weight through exercise and diet. The initiation of intragastric balloon treatment for Americans will enable patients to access a minimally invasive non-surgical approach for treating obesity and other weight-related diseases. Moreover, the FDA approval of the intragastric balloon, especially in clinics, is vital in countering the wave of obesity.

Asia Pacific will be the Dominating region by 2028
The high prevalence of obesity and an increase in related medical complications in Japan, China, and India are set to propel market growth in the Asia Pacific region, considerably. Obesity and being overweight has turned into an epidemic in developing countries, leading to health conditions like diabetes and other cardiovascular diseases. Thus, the use of intragastric balloons to treat and manage obesity has grown in popularity, across the region.
There is a moderate competition among the manufacturers within the global intragastric balloon market, as the key competitors are established. The enterprises focused on research and development, and product innovations, continue to expand their territory to seize market share. Thus, the competitive rivalry in the marker analyzed is moderate to high. Some of the distinguished companies in the market are Allergan Inc, Apollo Endosurgery Inc, Medsil, Helioscopie SA, Endalis, etc.

Related Reports:
GLOBAL COSMETIC SURGERY AND PROCEDURE MARKET
GLOBAL BARIATRIC SURGERY MARKET
GLOBAL PULSE OXIMETER MARKET

Inkwood Research
169, Harrison Avenue
Boston, MA 02111
Tel: 1-(857)293-0150
Email: sales@inkwoodresearch.com
Website: www.inkwoodresearch.com

We at Inkwood research provide you with not just consulting services but also with syndicated and customized research reports which help advance your business further.

This release was published on openPR.